Two-year prognosis and cardiovascular disease prevention after acute coronary syndrome: the role of cardiac rehabilitation—a French nationwide study
Authors' conclusion
Patients who received CR after hospitalization for ACS had a better prognosis.
Study context
- Population
- All patients hospitalized for acute coronary syndrome (ACS) in France in 201922% received cardiac rehabilitation (CR)
- Participants
- 134,846 patients
- Exposure
- CR vs no CR after ACS
- Outcome
- All-cause mortality
- Follow-up
- 2 years after ACS
Methodological detailsnationwide, National Health Insurance database
- Nationwide
- National Health Insurance database
Main finding
As reported in the abstract
CR vs non-CREstimate (95% CI)
Adjusted for confounders
adjusted HR 0.65(0.61–0.69)
Further adjusted for CV drug dispensing and cardiologic follow-up
HR 0.90(0.84–0.95)
Observational data: associations, not effects.
Further findings
- Persistence of BASI drugs (beta-blockers, antiplatelets, statins, RAAS inhibitors) · 1 year — non-CR
- 60%
Persistence of BASI drugs (beta-blockers, antiplatelets, statins, RAAS inhibitors) · 1 year
- Higher BASI persistence and medical follow-up rate with CR
Medical follow-up · 2 years
- Better medical follow-up with CR
Original publication
Two-year prognosis and cardiovascular disease prevention after acute coronary syndrome: the role of cardiac rehabilitation—a French nationwide study. Eur J Prev Cardiol. Published 4 June 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →